MIF and fatty liver disease: We demonstrate that obese MIF−/− mice have reduced hepatomegaly, lower systemic ALT levels and are partially protected from HFD-induced hepatic steatosis; coincident with reduced Pparγ and Srebp-1c mRNA expression compared to WT.